Fluorouracil (Sandoz Inc)
Welcome to the PulseAid listing for the Fluorouracil drug offered from Sandoz Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Fluorouracil |
SUBSTANCE NAME: | FLUOROURACIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-09-10 |
END MARKETING DATE: | 0000-00-00 |
Fluorouracil HUMAN PRESCRIPTION DRUG Details:
Item Description | Fluorouracil from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 2008-09-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66758-044_19dd287f-9d5d-4742-913f-25afa34bf277 |
PRODUCT NDC: | 66758-044 |
APPLICATION NUMBER: | ANDA040772 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers: